Kursprognose für Nurix Therapeutics Inc (NRIX)NRIXNurix Therapeutics Inc

Alphio's NRIX stock price prediction model matches the current Nurix Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.73 (+1.54%). The 1-week path is $26.60 (+4.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nurix Therapeutics Inc is a good buy right now due to its recent collaboration with Roche, which has significantly bolstered its financial outlook with an upfront payment of $700 million and potential milestone payments up to $2.3 billion. The stock has shown a strong upward trend with a 1-year change of +111.52% and a current price of $25.34, which is below the average analyst price target of $33. This provides a solid upside potential of approximately 30% from the current price. However, the main risk is the company's recent net income loss of $87,174,000 in Q1 2026, which indicates ongoing financial challenges that investors should monitor closely.

Nurix Therapeutics Inc (NRIX) last closed at $25.34, losing -0.67%. These facts feed the 1-day and 1-week NRIX price prediction above.